Management and treatment of glomerular diseases (part 2)

Rovin, Brad H.; Caster, Dawn J.; Cattran, Daniel C.; Gibson, Keisha L.; Hogan, Jonathan J.; Moeller, Marcus J.; Roccatello, Dario; Cheung, Michael; Wheeler, David C.; Winkelmayer, Wolfgang C.; Floege, Jürgen; Adler, Sharon G.; Alpers, Charles E.; Ayoub, Isabelle; Bagga, Arvind; Barbour, Sean J.; Barratt, Jonathan; Chan, Daniel T.M.; Chang, Anthony; Choo, Jason Chon Jun; Cook, H. Terence; Coppo, Rosanna; Fervenza, Fernando C.; Fogo, Agnes B.; Fox, Jonathan G.; Glassock, Richard J.; Harris, David; Hodson, Elisabeth M.; Hoxha, Elion; Iseki, Kunitoshi; Jennette, J. Charles; Jha, Vivekanand; Johnson, David W.; Kaname, Shinya; Katafuchi, Ritsuko; Kitching, A. Richard; Lafayette, Richard A.; Li, Philip K.T.; Liew, Adrian; Lv, Jicheng; Malvar, Ana; Maruyama, Shoichi; Mejía-Vilet, Juan Manuel; Mok, Chi Chiu; Nachman, Patrick H.; Nester, Carla M.; Noiri, Eisei; O'Shaughnessy, Michelle M.; Walters, Giles D.

Management and treatment of glomerular diseases (part 2)

Date

2021

Authors

Winkelmayer, Wolfgang C.

Abstract

In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to discuss the 2012 KDIGO glomerulonephritis guideline in the context of new developments and insights that had occurred over the years since its publication. During this KDIGO Controversies Conference on Glomerular Diseases, the group examined data on disease pathogenesis, biomarkers, and treatments to identify areas of consensus and areas of controversy. This report summarizes the discussions on primary podocytopathies, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated nephritis, complement mediated kidney diseases, and monoclonal gammopathies of renal significance.